AIDS Drugs: The Big Question
A one-hour TV program featuring Dr. David Rasnick and Professor Sam Mhlongo
A prime-time television debate on AIDS drugs taped before a live audience in South Africa. The program features Dr. David Rasnick, a former developer of protease inhibitors and his colleague, the former head of family medicine at South Africa's largest teaching hospital, Professor Sam Mhlongo. Together they challenge the safety and efficacy of anti-retroviral therapy and two doctors who hold mainstream opinions on the drugs. Go here and click on The Big Question.

Almost as informative as the program are Dr. Rasnick's comments: "Normally the program airs live but our opponents were able to prevent that. Instead, the show was videotaped with two endings, depending on how the audience vote turned out. Sam and I won the debate, but it took pressure from the government, the threat of a law suit and an editorial in a South African newspaper on freedom of speech to finally get the program aired two weeks later. There were supposed to be three programs, but the other two never had a chance. More important than the arguments, I believe, is the difference between how Sam and I behave compared to our opponents. See what you think..."

Stories on Drug Success Prove You're Wrong
A letter to Christine and a reply

Anti-HIV Drugs Fail to Increase HIV Patients Lifespan
By Neville Hodgkinson
The widespread belief that the latest drugs for fighting AIDS are reducing death rates has been confounded by a huge study covering 10 years of treatment and more than 22,000 patients in Europe and North America. The results: No decrease in overall death rates, and in fact, patients¹ risk of developing or dying from Aids has actually increased in recent years.

New AIDS Drug Study is Flawed and Biased
Scientists Say There's No Proof Taking AIDS Drugs is Better Than Taking Nothing
Responding to a study on AIDS drugs published in the Nov. 30, 2006 issue of the New England Journal of Medicine (NEJM), scientists from the non-profit public interest group Rethinking AIDS state the trial's conclusions are flawed and that the idea that AIDS drug interruptions are dangerous is based on unproven assumptions. According to Dr. Etienne de Harven, a pioneer in virology research and electron microscopy and President of RA, “The NEJM study does not provide evidence that taking AIDS drugs is better than not taking them..."

The AIDS Debate: The Most Controversial Story You’ve Never Heard
Part Two: AIDS Drug Controversy
By Liam Scheff
Through a series of questions and answers, various experts simply and effectively outline the basis for the AIDS debate and the controversy over HIV. This is part two of a three part series. Part one covers the AIDS controversy (see Related Articles in Rethinking AIDS) and part three takes on AIDS in Africa (see Related Articles in Africa in Perspective)

The Trouble With Nevirapine
By Anthony Brink
An informative expose on the controversial AIDS treatment drug Nevirapine authored by a South African legal expert. This 200 page document reads like a sophisticated crime novel and the facts it presents are as harrowing and as they are important.

Drugs, Disease, Denial
By Celia Farber
"We cannot say that protease inhibitors are useless. In 1996 when they started to use protease inhibitors, there is no doubt that there was a change. Before 1996, all the people who used AZT were killed. There was no benefit there. Protease inhibitors have benefits they are antioxidants. No doubt they are poison and in the long run they kill the person, but you need proteases in the process of oxidation these drugs are also antibiotics."

forward to If It's Not HIV...